• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Plus Therapeutics Inc (NQ: PSTV )

    1.500 +0.030 (+2.04%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 37,517
    Open 1.450
    Bid (Size) 1.470 (39)
    Ask (Size) 1.510 (8)
    Prev. Close 1.470
    Today's Range 1.450 - 1.650
    52wk Range 0.9694 - 3.210
    Shares Outstanding 2,879,620
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    PSTV Stock Earnings: Plus Therapeutics Beats EPS, Misses Revenue for Q1 2024
    PSTV stock results show that Plus Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense
    Plus Therapeutics will secure $3 million in funding from the Department of Defense for pediatric brain cancer trial expansion. 
    Via Benzinga

    Performance

    YTD
    -18.92%
    -18.92%
    1 Month
    -33.33%
    -33.33%
    3 Month
    -16.66%
    -16.66%
    6 Month
    -18.92%
    -18.92%
    1 Year
    -26.57%
    -26.57%

    More News

    Read More
    PSTV Stock Earnings: Plus Therapeutics Beats EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Recap: Plus Therapeutics Q4 Earnings
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Insiders Buying Plus Therapeutics And 2 Other Stocks Under $2
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Plus Therapeutics Stock Popped Today
    Via Benzinga
    Earnings Outlook For Plus Therapeutics
    Via Benzinga
    Earnings Scheduled For March 5, 2024
    Via Benzinga
    Plus Therapeutics Earnings Preview
    Via Benzinga
    Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Why Is Liquid Biopsy Firm Biocept Stock Trading Lower Today?
    Via Benzinga
    Topics Bankruptcy
    Exposures Financial Legal
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Earnings Scheduled For October 31, 2023
    Via Benzinga
    Plus Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Is Cancer Diagnostic Focused Biocept Stock Trading Higher Today?
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancers
    Via Benzinga
    Plus Therapeutics Presents Exciting New Clinical Data At Top Cancer Conference
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.